Axon Guidance Molecules in Nigrostriatal Regeneration
黑质纹状体再生中的轴突引导分子
基本信息
- 批准号:6888124
- 负责人:
- 金额:$ 16.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-06-01 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:Parkinson&aposs diseaseaxoncentral neural pathway /tractcorpus striatumdevelopmental neurobiologydopaminegrowth conesimmunocytochemistryin situ hybridizationlaboratory mouselaboratory ratlaser capture microdissectionligandsmessenger RNAnerve /myelin proteinnervous system regenerationneural degenerationneurogenesisneuronal guidanceneuronal transportpolymerase chain reactionreceptorsubstantia nigra
项目摘要
DESCRIPTION (provided by applicant): We are interested in developing strategies for the reconstitution of the dopaminergic (DA) nigrostriatal (NS) pathway that degenerates in Parkinson's disease, an important goal because of the inadequacy of current long-term treatments. Attempts to reconstruct this pathway through transplantation of precursor cells or neurons into the nigra of the adult fail, likely as a result of 1) the presence of inhibitory molecules and/or 2) the absence of trophic and guidance molecules in the adult CNS. Here we propose that an understanding of the molecular events that regulate the development of the nigrostriatal pathway will provide insights for strategies designed to improve NS pathway regeneration in the adult milieu. We propose - and have exciting preliminary data to support - that axon guidance molecules (AGMs), important molecules that direct the development of other projection pathways in the CNS, are expressed in the developing DA NS pathway. A series of experiments are proposed to elucidate the role played by AGMs and their receptors in the development of the NS pathway. Our specific aims are to: 1) Define those AGMs whose receptors are expressed in the developing axons of nigral DA neurons; 2) Define the expression of AGM ligands in relation to the developing NS pathway; 3) For those AGMs that are expressed in an appropriate anatomical relationship to influence NS development, and whose receptors are expressed in developing DA neurons, directly demonstrate chemotropic effects on fetal nigral DA neurons in vitro, and their importance in the development of the NS pathway with blocking studies ex vivo. The outcome of the experiments outlined in this proposal will hopefully be the refinement of means to counteract the inhibitory milieu of the adult injured nervous system, and recapitulate the attractive and repulsive factors that direct axonal outgrowth during development, thereby paving the way for novel reconstructive and regenerative strategies to ameliorate the symptoms of Parkinson's disease. The insights derived from these studies may also have applicability in other neurodegenerative diseases, brain injury and stroke. The research outlined is part of a customized five-year plan of training and career development for the Principal Investigator. The proposal includes active mentoring by experienced scientists, access to diverse resources, and an environment uniquely suited to help the PI develop as an independent neurosurgeon-neuroscientist.
描述(由申请人提供):我们有兴趣制定策略来重建多巴胺能(DA)nigrostriatal(NS)途径,该途径在帕金森氏病中退化,这是当前长期治疗不足的重要目标。试图通过将前体细胞或神经元移植到成人的NIGRA失败中来重建这一途径,这可能是由于1)存在抑制性分子和/或2)成人CNS中不存在营养和指导分子。在这里,我们建议对调节黑质纹状体途径发展的分子事件的理解将为旨在改善成人环境中NS途径再生的策略提供见解。我们提出的 - 并有令人兴奋的初步数据来支持 - 轴突引导分子(AGM)是指导中枢神经系统中其他投影途径发展的重要分子,在发展中的DA NS途径中表达。提出了一系列实验,以阐明AGM及其受体在NS途径发展中所起的作用。我们的具体目的是:1)定义那些受体在nigral da神经元发展的轴突中表达的AGM; 2)定义与发育中的NS途径相关的AGM配体的表达; 3)对于那些在适当的解剖学关系中表达的AGM,以影响NS发育,其受体在发展DA神经元中表达,直接在体外表现出对胎儿nigral DA神经元的趋化作用,以及它们在NS途径中通过阻止研究的NS途径的重要性。该提案中概述的实验结果有望成为抵制成人受伤神经系统抑制环境的手段,并概括了在发育过程中导致轴突生长的有吸引力和排斥性因素,从而铺平了新的重建性和再生策略,以使新的重建性和再生策略适应parkinson的疾病。从这些研究中得出的见解也可能在其他神经退行性疾病,脑损伤和中风中适用。该研究概述是首席研究人员定制的五年培训和职业发展计划的一部分。该提案包括经验丰富的科学家的积极指导,获得各种资源的机会,以及一个独特的环境,非常适合帮助PI作为独立的神经外科医生 - 神经科学家发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT E GROSS其他文献
ROBERT E GROSS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT E GROSS', 18)}}的其他基金
Development and validation of a viral vector for targeted inhibition of DG granule cells
用于靶向抑制 DG 颗粒细胞的病毒载体的开发和验证
- 批准号:
10648833 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别:
Data-driven optimization for DBS programming in temporal lobe epilepsy
颞叶癫痫 DBS 编程的数据驱动优化
- 批准号:
10574839 - 财政年份:2022
- 资助金额:
$ 16.69万 - 项目类别:
Development of a self-regulated neuroprotective gene therapy for Parkinsons Disease and other synucleinopathies
开发针对帕金森病和其他突触核蛋白病的自我调节神经保护基因疗法
- 批准号:
9809188 - 财政年份:2019
- 资助金额:
$ 16.69万 - 项目类别:
相似国自然基金
中脑多巴胺神经元轴突结构和功能及其异常的机制研究
- 批准号:31630029
- 批准年份:2016
- 资助金额:282.0 万元
- 项目类别:重点项目
神经元轴突起始节异常在老年性痴呆症的发生发展中的作用
- 批准号:31630028
- 批准年份:2016
- 资助金额:267.0 万元
- 项目类别:重点项目
颞叶癫痫早期抑制Gadd45b表达对海马齿状回病理结构形成的影响及表观遗传机制
- 批准号:31671249
- 批准年份:2016
- 资助金额:61.0 万元
- 项目类别:面上项目
对神经细胞轴突起始段中支架蛋白Ankyrin-G介导的蛋白复合物的结构与功能研究
- 批准号:31670734
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
RTN3 在缺血性中风致脑白质轴突溃变的作用及其分子机制的研究
- 批准号:81571197
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
相似海外基金
Physiological Function of Persistent Inward Currents in Motor Neurons
运动神经元持续内向电流的生理功能
- 批准号:
10663030 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别:
A new in vivo zebrafish model to study alpha-synuclein aggregation in Lewy Body Disease
研究路易体病中α-突触核蛋白聚集的新体内斑马鱼模型
- 批准号:
10731005 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别:
Isolating region specific α-syn-mediated mechanisms in mitochondrial function in vivo
体内线粒体功能中分离区域特异性 α-syn 介导的机制
- 批准号:
10809994 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别:
The effect of aging on neurotransmitters and motor performance in a primate model
衰老对灵长类动物模型中神经递质和运动表现的影响
- 批准号:
10573386 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别:
Preservation of brain NAD+ as a novel non-amyloid based therapeutic strategy for Alzheimer’s disease
保留大脑 NAD 作为阿尔茨海默病的一种新型非淀粉样蛋白治疗策略
- 批准号:
10588414 - 财政年份:2023
- 资助金额:
$ 16.69万 - 项目类别: